B Cell Epitopes of Four Fimbriae Antigens of Klebsiella pneumoniae: A Comprehensive In Silico Study for Vaccine Development by Zargaran, F.N. et al.
Vol.:(0123456789) 
International Journal of Peptide Research and Therapeutics (2021) 27:875–886 
https://doi.org/10.1007/s10989-020-10134-3
B Cell Epitopes of Four Fimbriae Antigens of Klebsiella pneumoniae: 
A Comprehensive In Silico Study for Vaccine Development
Fatemeh Nemati Zargaran1 · Alisha Akya1 · Shahab Rezaeian1 · Keyghobad Ghadiri1 · Roya Chegene Lorestani1 · 
Hamid Madanchi2,3 · Sadegh Safaei4,5 · Mosayeb Rostamian1 
Accepted: 28 October 2020 / Published online: 24 November 2020 
© Springer Nature B.V. 2020
Abstract
Klebsiella pneumoniae is one of the major causes of nosocomial infections worldwide which can cause several diseases in 
children and adults. The globally dissemination of hyper-virulent strains of K. pneumoniae and the emergence of antibiotics-
resistant isolates of this pathogen narrows down the treatment options and has renewed interest in its vaccines. Vaccine 
candidates of Klebsiella pneumoniae have not been adequately protective, safe and globally available yet. In K. pneumoniae 
infection, it is well known that B cells that induce robust humoral immunity are necessary for the host complete protection. 
Identifying the B cell epitopes of antigens is valuable to design novel vaccine candidates. In the present study using immu-
noinformatics approaches we found B cell epitopes of four K. pneumoniae type 1 fimbriae antigens namely FimA, FimF, 
FimG, and FimH. Linear and conformational B cell epitopes of each antigen were predicted using different programs. Sub-
sequently, many bioinformatics assays were applied to choose the best epitopes including prediction antigenicity, toxicity, 
human similarity and investigation on experimental records. These assays resulted in final four epitopes (each for one Fim 
protein). These final epitopes were modeled and their physiochemical properties were estimated to be used as potential vac-
cine candidates. Altogether, we found four B cell epitopes of K. pneumoniae Fim antigens that are immunogen, antigenic, 
not similar to human peptides, not allergen and not toxic. Also, they have suitable physiochemical properties to administrate 
as vaccine, although their complete efficacy should be also shown in vitro and in vivo.
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Introduction
Klebsiella pneumoniae is one of the major causes of noso-
comial infections worldwide (Podschun and Ullmann 1998). 
K. pneumoniae colonizes the humans gastrointestinal tract 
and it is able to cause infection if gains entry to the blood 
and other tissues (Piperaki et al. 2017). It can cause menin-
gitis and sepsis in neonates and infants in pediatric wards 
as well as serious infections in immunocompromised chil-
dren and adults. K. pneumoniae is also one of the causative 
agents for community acquired pneumonia (Piperaki et al. 
2017). The hospitalization and mortality rate for patients 
infected by K. pneumoniae is varying among different 
countries. As an instance, the overall hospitalization and 
mortality rate for patients with pneumonia caused by K. 
pneumoniae in the United States is 3.6 cases/100,000 popu-
lation and 14.3%, respectively, where the hospitalization rate 
has increased since 2002 to 2011 (Wuerth et al. 2016).The 
worldwide pooled mortality rate of patients infected with 
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carbapenem- resistant and carbapenem-susceptible K. pneu-
moniae was reported to be 42.14% and 21.16%, respectively 
(Xu et al. 2017).
A significant increase of more than 40% in antibiotic 
resistance has been reported for K. pneumoniae which is 
mainly observed for the following antibiotics: cefazo-
lin, cefuroxime, amoxicillin-clavulanic acid, ceftriaxone, 
cefepime, and ceftazidime (Kahraman and Çiftcia 2017). 
The globally dissemination of hyper-virulent strains of K. 
pneumoniae and the emergence of antibiotics-resistant iso-
lates of this pathogen narrows down the treatment options 
and has renewed interest in its vaccines. A number of vac-
cine candidates including inactivated whole cell vaccines, 
capsular polysaccharides, outer membrane vesicles, and 
highly conserved immunogenic proteins have been proposed 
for prevention of K. pneumoniae infections. A clinical trial 
aiming K. pneumoniae prevention evaluated a multicom-
ponent vaccine called Immunovac in patients with chronic 
pulmonary diseases (Egorova et al. 2010). This vaccine 
contained antigenic complexes derived from K. pneumo-
niae, P. vulgaris, S. aureus, and E. coli and was observed 
to be immunogenic in elderly patients and preschool chil-
dren (Egorova et al. 2010). However, in spite of numerous 
attempts, vaccine candidates for K. pneumoniae prevention 
have not been fully protective, safe and globally available 
yet, demanding new strategies to find more efficient anti-
gens to develop effective vaccine (Pletz et al. 2016; Choi 
et al. 2019).
Vaccine studies in vivo and in vitro are time-consuming 
and costly processes. Using bioinformatics approaches such 
as in silico epitope prediction can make these processes eas-
ier by introducing novel or characterizing previous found 
vaccine candidates (He et al. 2010).
Fimbriae proteins of K. pneumoniae have been shown to 
be effective protein carriers and immunogens (Li et al. 2010; 
Staniszewska et al. 2000; Lavender et al. 2005; Witkowska 
et al. 2005; Babu et al. 2017). However, vaccines candidates 
based on these proteins are at the primarily stages of devel-
opment and require more studies (Choi et al. 2019). Type 
1 fimbriae is composed of 1000 units of FimA (the major 
subunit) and single copies of FimF (the adaptor subunit), 
FimG (the tip subunit), and FimH (the adhesion) proteins 
(Volkan et al. 2014).
It is accepted that humoral (antibody) responses play 
a critical role in controlling of K. pneumoniae infections. 
The anti-K. pneumoniae antibodies evoked in experimen-
tal animals have been shown to cause a protective response 
(Libon et al. 2002; Lee et al. 2015; Hegerle et al. 2018). 
B cell-specific epitopes are linear or discontinuous amino 
acid sequences that induce specific, desirable, and broad-
spectrum humoral immunity (Chyau Liang 1998). Defining 
these epitopes will assist to find and characterize the novel 
vaccine candidates for this gram-negative pathogen.
In our previous work, we predicted T cell epitopes of 
four type 1 fimbriae antigens namely FimA, FimF, FimG, 
and FimH using immunoinformatic, docking and molecular 
dynamics (Rostamian et al. 2020). Due to the importance of 
humoral immune responses against K. pneumoniae, here we 
performed an in silico study on these four Fim antigens as 
vaccine candidates and tried to find and characterize B-cell 
epitopes of these antigens. Furthermore, the selected B cell 
epitopes were modeled and their physiochemical properties 
were estimated to be used as potential vaccine candidates.
Methods
Sequences Preparation
The sequences of the single proteins of FimA (acces-
sion number: CDO12578.1), FimF (accession number: 
CDO12574.1), FimG (accession number: CDO12573.1) and 
FimH (accession number: CDO12572.1) were retrieved from 
NCBI protein database (https ://www.ncbi.nlm.nih.gov/prote 
in). Note that in K. pneumoniae type 1 fimbriae a bunch of 
about 1000 identical FimA subunits are present, but here we 
only select one single subunit of FimA.
Linear B‑Cell Epitope Prediction
For prediction of linear epitopes, the Fim protein sequences 
were submitted to the IEDB (https ://tools .iedb.org/main/
bcell /), (Fleri et al. 2017), and ABCpred (https ://crdd.osdd.
net/ragha va/abcpr ed/) (Saha and Raghava 2006) servers. 
The IEDB server contains five tools to predict linear B-cell 
epitopes that are based on the following scales: hydrophilic-
ity (Parker et al. 1986), beta turn (Chou and Fasman 2006), 
surface accessibility (Emini et al. 1985), flexibility (Kar-
plus and Schulz 1985), and antigenicity (Kolaskar and Ton-
gaonkar 1990). At the first step, the linear B-cell epitopes 
of Fim proteins were predicted by these five tools. For each 
tool, as recommended by the tool, the window size was set 
on seven amino acid residues and the threshold was set on 
the defaults provided by the tool. Each tool provided a chart 
in which regions with scores higher than threshold are more 
probable to be B-cell epitope. All charts provided by the 
tools were compared and the regions that predicted to be 
epitopes in at least three (out of five) tools were selected for 
further analysis.
Also, two other linear B-cell epitope prediction programs 
namely BepiPred 1.0 (Larsen et al. 2006) and BepiPred 2.0 
(Jespersen et al. 2017) can be found in the IEDB server. 
BepiPred 1.0 use algorithms that combined hidden Markov 
model and a propensity scale method, while BepiPred 2.0 
use a Random Forest algorithm trained on epitopes and non-
epitope amino acid residues found from crystal structures 
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(Larsen et al. 2006; Jespersen et al. 2017). Similar to above 
mentioned B-cell epitope prediction tools, these tools also 
report their analyses by charts in which the regions with 
scores higher than threshold are defined as epitopes.
To find more probable linear B-cell epitope, ABCpred 
server was also applied. This server predicts epitopes using 
artificial neural network (Saha and Raghava 2006). The pro-
teins sequences were submitted and other parameters were 
remained as default. The server presents the more probable 
linear epitopes ranked according to their score when higher 
score means the higher probability to be epitope.
Finally, to find similar predicted epitopes, all the epitopes 
obtained from IEDB (seven tools) and ABCpred were com-
pared using Epitope Cluster Analysis tool (https ://tools .iedb.
org/clust er/) and the common epitopes were selected as final 
linear B-cell epitopes.
Modelling of Fim proteins
For prediction of conformational B-cell epitopes, the pre-
dictors need tertiary structures of our proteins. Since the 
3D structures of our proteins were not available in the PDB 
bank, the structures of Fim proteins were obtained by mode-
ling using SWISS-MODEL server (https ://swiss model .expas 
y.org/, (Waterhouse et al. 2018)).
The amino acid sequence of Fim proteins were submitted 
to the server. Following target-template alignment, the server 
found and used the available 3D structure of proteins similar 
to Fim (usually Fim proteins of other bacteria) as templates. 
The model accuracy and modeling errors were estimated by 
the qualitative model energy analysis1 (QMEAN) scoring 
function supplied by the server (Waterhouse et al. 2018). 
Also, the quality of models was assessed by generation of 
Ramachandran plot using RAMPAGE server (https ://mordr 
ed.bioc.cam.ac.uk/~rappe r/rampa ge.php, (Lovell et  al. 
2003)).This server use Ramachandran plots to predict the 
possibility of amino acids to form a secondary structure and 
show the qualities of models based on the amino acid per-
centage in the allowed, favoured and outlier regions (Lovell 
et al. 2003).
Conformational B‑Cell Epitope Prediction
The 3D models of Fim proteins were submitted to DiscoTope 
2.0 (Kringelum et al. 2012) and ElliPro (Ponomarenko et al. 
2008) to predict conformational epitopes. The parameters 
were remained as the tools defaults. Each tool predicts one 
or more regions as epitopes. The regions common in pre-
dicted epitopes of two tools were considered as final con-
formational epitopes.
Toxicity, Human Similarity, and Experimental 
Records
The linear epitopes and the segment sequences of con-
formational epitopes were checked for potential toxicity 
using ToxinPred server (Gupta et al. 2013). The epitopes 
sequences were entered as FASTA format, the support-
vector machine2 (SVM) algorithm was selected and other 
parameters were left as the server defaults.
By searching in BLASTP (https ://blast .ncbi.nlm.nih.gov/
Blast .cgi?PAGE=Prote ins), selected linear and conforma-
tional epitopes were screened for similarity with human 
proteome (taxid 9606). The epitopes with ≥ 90% similarity 
with human peptides (at both coverage and identity values) 
were excluded from the study.
The shortlisted epitopes were investigated for possible 
experimental records using the home page of IEDB (https ://
www.iedb.org/) by selecting human as the host and applying 
each epitope as query.
Antigenicity and Allergenicity
Antigenic regions of Fim proteins were predicted using 
the antigenic program of the European Molecular Biology 
Open Software Suite3 (EMBOSS) (https ://www.bioin forma 
tics.nl/cgi-bin/embos s/antig enic) that predicts antigenicity 
using the method of Kolaskar and Tongaonkar (1990). The 
amino acid sequences of Fim proteins were entered to the 
program separately and other parameters were remained as 
defaults. The output represents amino acid sequences with 
different lengths and different scores that are potentially 
antigenic regions. These predicted regions were clustered 
with previously predicted linear and conformational epitopes 
using Epitope Cluster Analysis tool (https ://tools .iedb.org/
clust er/). The Fim regions that have been predicted in both 
linear/conformational epitope prediction and antigenicity 
prediction were selected as the best B-cell epitopes.
Presence of antigenic sequence in these selected epitopes 
was also confirmed by Antigenic Peptide Prediction4 (APP) 
software (https ://imed.med.ucm.es/Tools /antig enic.pl). 
APP predicts those segments within a protein or a peptide 
sequence that are likely to be antigenic by eliciting an anti-
body response by Kolaskar and Tongaonkar method (1990).
The allergenicity of the final peptides was checked by 
Structural Database of Allergenic Proteins5 (SDAP) (Ivan-
ciuc 2003) and AllerCatPro (Maurer-Stroh et  al. 2019) 
servers.
1 QMEAN: qualitative model energy analysis.
2 SVM: support-vector machine.
3 EMBOSS: European Molecular Biology Open Software Suite.
4 APP: Antigenic Peptide Prediction.
5 SDAP: Structural Database of Allergenic Proteins.
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3D Structure and Other Physicochemical Properties 
of Final Epitopes
The PEP-Fold3 server (https ://biose rv.rpbs.univ-paris -dider 
ot.fr/servi ces/PEP-FOLD3 /2018) was used to predict the ter-
tiary structure of selected epitopes (Lamiable et al. 2016). 
To achieve the other physicochemical properties of epitopes, 
ProtParam from Expasy (https ://web.expas y.org/protp aram/) 
was used (Adhikari et al. 2018). These properties included 
molecular weight, half-life, instability index, net charge, 
hydrophobicity, grand average of hydropathicity index6 
(GRAVY), and isoelectric pH7 (pI).
Moreover, helical wheel projection was carried out to 
predict the position of amino acids in peptides by Heliquest 
server (https ://heliq uest.ipmc.cnrs.fr/cgi-bin/Compu tPara 
ms.py) (Gautier et al. 2008).
Results
Linear B‑Cell Epitope Prediction
A B-cell linear epitope search was performed for all Fim 
proteins using the IEDB (seven tools) and ABCpred. Each 
tool in the IEDB provided a chart in which regions with 
scores higher than threshold were more probable to be B-cell 
epitope. These charts are presented in Figs. S1, S2, S3, and 
S4. After comparison of all charts provided by the tools the 
regions that predicted to be epitopes in at least five (out of 
seven) tools were selected. Then, these selected epitopes 
were compared to the results of ABCpred tool and clustered 
using cluster analysis tool with cut-off set on ≥ 70% similar-
ity. Only one epitope of each cluster was selected as final 
linear B-cell epitope which was the one that had the highest 
prediction scores or had been predicted by more prediction 
tools. The number of epitopes predicted by each tool and the 
selected linear B-cell epitopes of each antigen is presented 
in Table 1.
Modelling of Fim Proteins
The 3D structures of Fim proteins were modeled by SWISS-
MODEL server based on target-template alignment. Regard-
ing quality estimations provided by the server, the models 
were created with high quality and accuracy (Fig. 1a–c).
Furthermore, the quality of models was also confirmed by 
Ramachandran plotting that revealed large portions of amino 
acid in the favored regions (Fig. 1d).
Conformational B‑Cell Epitope Prediction
The created models of Fim proteins were submitted to Dis-
coTope 2.0 and ElliPro to predict conformational B-cell 
epitope of each antigen. The tools predicted epitopes with 
different scores. The outputs were compared and the regions 
predicted to be epitope in both tools or had gotten the highest 
score by the tools were considered as final conformational 
epitopes. The number of predicted epitopes by each tool and 
the selected conformational epitopes has been represented 
in Table 2. The locations of selected conformational epitope 
residues for each Fim protein have also been illustrated in 
Fig. 2.
Toxicity, Human Similarity, and Experimental 
Records
The toxicity, human similarity and experimental records 
investigations were performed for the selected linear 
epitopes and the segment sequences of conformational 
epitopes. For predicting toxicity the ToxinPred server com-
pared our peptides with 1805 toxic peptides to find any pos-
sible homology of our peptides and these toxic peptides. 
The results of toxicity prediction showed that none of our 
selected epitopes was toxic for humans. Comparison of 
the epitopes with human proteome showed that only two 
epitopes (TAGSTSS of FimA and TADSTGY of FimG) 
were completely similar (100% identity and 100% coverage) 
with human peptides, hence were excluded. No experimental 
record was found for any of our selected epitopes.
Antigenicity Prediction
The antigenicity prediction resulted in the sequences with 
different lengths and different scores that were potentially 
antigenic regions (Table 3). These regions were clustered 
with our previously predicted linear and conformational 
epitopes and the common regions between them were 
selected as the best B-cell epitopes. In case more than one 
common region existed, only one region was selected which 
had been predicted by more tools or had higher prediction 
scores (Table 4). Furthermore, for these final peptides APP 
software predicted that there are antigenic determinants in 
all of them confirming their high immunogenicity (Table 4).
The allergenicity prediction results showed that none of 
our final epitopes are allergen.
Structural and Physicochemical Properties 
Prediction
To simplify the explanations of the results for physicochemi-
cal and structural prediction, the symbols of the epitopes 
(as Table 4) were used. The physicochemical properties of 
6 GRAVY: grand average of hydropathicity index.
7 pI: isoelectric pH.
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final epitopes including molecular weight, half-life, insta-
bility index, net charge, hydrophobicity, GRAVY, and pI 
have been presented in Table 5. These results showed that 
BEF-G and BEF-H were naturally basic, stable, and hydro-
philic while BEF-A sequence was acidic, stable and less 
hydrophilic. BEF-F was also acidic, hydrophilic but unsta-
ble. Hydrophobic and hydrophilic faces of each peptide were 
drawn up by helical wheel projection (Fig. 3).
The prediction results of the 3D structure of the pep-
tides revealed that BEF-A and BEF-F are mixture of helix 
and coil while BEF-G and BEF-H are a combination of 
β-sheet, turn and coil (Fig. 4).
Table 1  The number of predicted and the selected linear B-cell epitopes
*Number of epitopes predicted by each tool
**The selected epitopes of each antigen (those predicted by a tool are shown by "+")
Prediction tool Ep. No.* Selected epitopes**
TTTVNGG CDTTVAT TAGSTSS VNGGTVH AIDSSNT
FimA Antigenicity 97 − + − + −
Beta turn 78 + + + + +
Flexibility 94 + + + + +
Hydrophilicity 99 + + + + +
Surface accessibility 68 + − + − +
BepiPred 1.0 11 + + + + +
BepiPred 2.0 7 + − + − −
ABCpred 13 + + − + +
GESKDFT PVNAPSS QSRLPVN
FimF Antigenicity 87 − + +
Beta turn 77 + + +
Flexibility 77 + + +
Hydrophilicity 82 + + +
Surface accessibility 63 + + +
BepiPred 1.0 10 + + +
BepiPred 2.0 6 + − −
ABCpred 13 + + +
TADSTGY QNEDGTT YKNQGTA LNNGSSQ TGYYKNQ
FimG Antigenicity 83 − − − − −
Beta turn 68 + + + + +
Flexibility 69 + + + + +
Hydrophilicity 85 + + + + +
Surface accessibility 52 + + + + +
BepiPred 1.0 7 + + + + +
BepiPred 2.0 5 + + + + +
ABCpred 18 + + + + +
TNNYNSD SRTDKPW GTTADSA QTNNYNS
FimH Antigenicity 157 − − − −
Beta turn 143 + + + +
Flexibility 141 + + + +
Hydrophilicity 155 + + + +
Surface accessibility 87 + + + +
BepiPred 1.0 17 − + + −
BepiPred 2.0 13 + − + +
ABCpred 29 + + + +
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Discussion
In the present study using immunoinformatics approaches 
we found B cell epitopes of four Fim proteins as vaccine can-
didates against K. pneumoniae. B cell epitopes may be linear 
or conformational. Linear epitopes are short sequences that 
elicit humoral responses even if the antigen administered 
in the denatured form. Conversely, conformational epitopes 
consist of atoms from distant amino acid residues joined on 
the surface of the antigens. These epitopes may be bound to 
either an immunoglobulin or a B cell receptor and triggers 
humoral responses (Chyau Liang 1998).
B-cell epitope prediction resulted in the final 5, 3, 5, and 
4 linear epitopes with 7-amino acid sequences. Since we 
defined the window size of prediction tools on 7, the pre-
dicted epitopes are all 7-amino acid sequences. It does not 
mean that all B-cell epitopes should be restrictively 7-amino 
acid length, but it means that these seven amino acids are 
the core of B-cell epitopes and almost always present in 
antibody-epitope interactions.
In contrast, conformational epitope predictions lead to 
different numbers of epitopes for each Fim antigen with vari-
ous sequence lengths. For FimA, a conformational epitope 
was found (amino acid number 29 to number 35) that had 
been also found by linear epitope prediction emphasiz-
ing the importance of this region as an epitope. For other 
Fim proteins, a conformational epitope was found for each 
antigen that composed of discontinues parts. There was no 
Fig. 1  Evaluation of the mod-
els quality. After homology 
modeling of Fim proteins, the 
model quality was evaluated 
by Local Quality Estimate 
(LQE Local Quality Estimate) 
(LQE) plots, Comparison with 
Non-redundant Set of PDB 
Structures, and Global Quality 
Estimate (GQE Global Quality 
Estimate) (GQE) prepared by 
SWISS-MODEL server, as well 
as by Ramachandran plotting 
by RAMPAGE server. In LQE 
plots (a), residues with a score 
above 0.6 are expected to be of 
acceptable quality. In com-
parison plots (b), whatever the 
model (indicated by a red star) 
is near to the dark grey region, 
the model has a higher quality. 
In GQE plots (c), for each term 
the Z-score number around zero 
shows better agreement between 
the models and experimental 
structures of similar size. The 
results of Ramachandran plots 
(d) are summarized in a table 
that show the percentage of 
amino acid residues in favored, 
allowed, and outlier regions
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Table 2  The number of predicted and the selected conformational B-cell epitopes
*Number of epitopes predicted by each tool
**The selected conformational epitope of each antigen. The conformational epitopes are composed of one or more segments. Each segment is 
separated by dash. The number of first and last amino acid residue of each segment is represented. The underlined bold sequences are the parts 
that were predicted by DiscoTope 2.0. The epitope is shown by "+" if predicted by the tool
# No epitope was found for FimF using DiscoTope 2.0
& This epitope is predicted by DiscoTope 2.0, but many segments of it were also present in a very large epitope predicted by Ellipro (not shown 
here)
Antigen Prediction tool Ep. No.* Selected epitope**
29NGGTVHF35
FimA DiscoTope 2.0 1 +
ElliPro 4 +
23ADSTIAISGYVRDNACA39-76SPCGTSVTA84-137TTLTPGQTN145-176Q #
FimF DiscoTope 2.0 0 −
ElliPro 3 +
24DVTLTVNGKVVARP37-77PVG79





FimH DiscoTope 2.0 1  + 
ElliPro 2  + 
Fig. 2  The locations of selected 
conformational epitope residues 
in Fim proteins. The location of 
selected epitopes are depicted 
by yellow color. The Fim A, 
FimF, and FimG epitope loca-
tion have been extracted from 
ElliPro server, while the FimH 
epitope was extracted from 
DiscoTope 2.0 server
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relationship between discontinues parts and the final pre-
dicted linear epitopes. However, it does not make a problem 
since conformational epitopes may not be necessarily associ-
ated with linear ones.
We applied many other assays to choose the best epitopes 
including prediction antigenicity, allergenicity, toxicity, 
human similarity and investigation on experimental records. 
These assays resulted in final four epitopes (each for one 
Fim protein) that were immunogen, antigenic, not similar 
to human peptides, not allergen and not toxic.
To find conformational epitops, prediction tools need 3D 
structure of the antigens.
If the tertiary structure of the antigens is known, the 
predicted tools can find the conformational epitopes more 
efficiently. Otherwise, in silico approaches provide a way 
to model the structure of the antigens and map their con-
formational epitopes. Accordingly, in the present study we 
modeled the Fim antigens using in silico approaches. Gen-
erally the quality estimations showed that our models are 
acceptable, although some quality scores were low for some 
models.
Although no study was found on our Fim antigens, there 
are some bioinformatics studies on other antigens of K. 
pneumoniae regarding B cell epitope mapping. In a study 
Table 3  The antigenicity 
prediction of Fim proteins
*The antigenic regions predicted by the antigenic program of EMBOSS
**The maximum score given by the antigenic program of EMBOSS. The higher numbers show regions 
with more antigenicity potency




































883International Journal of Peptide Research and Therapeutics (2021) 27:875–886 
1 3
done by Dar et al. 222 genomes of K. pneumoniae were 
explored and the core proteome was found and applied for 
a deep reverse vaccinology. They identified four antigens 
and predicted their B cell epitopes using ABCPred (Dar 
et al. 2019). By applying several bioinformatics approaches 
and based on conformational B cell and linear CD4+ T cell 
epitopes, Farhadi et al. engineered a polytopic vaccine using 
five Omps from K. pneumoniae (Farhadi et al. 2015). These 
Table 4  Final B-cell epitopes of 
Fim protein
*Antigenic region predicted by antigenic program of EMBOSS
**Antigenic determinant predicted by Antigenic Peptide Prediction (APP)
# Symboles were chosen from first letters of the phrase "B cell Epitope of Fim"
Antigen Parameter Sequence Epitope  symbol#




Antigenic determinant** GTVHFKGEVVNAAC 
FimF Final region GVEILDQQQSRLPVNAPSS BEF-F









FimH Final region TRNGSAVPANSTVSLGTVGTSPVNLGLTAT BEF-H
Linear epitope None
Conformational epitope TRNGSAVPANSTVSLGTVGTSPVNLG
Antigenic region* SAVPANSTVSLGTVGTSPVNLGLTAT 
Antigenic determinant** GSAVPANSTVSLGTVGTSPVNL





e Grand average of hydropathicity index
Epitope Mwa Estimated Half life Hydb (%) Ntc pId GRAVYe Instability index
BEF-A 2115.4 100 h (mammalian reticulocytes, in vitro) 50 − 0.75 5.32 0.459 − 1.23-Stable
 > 20 h (yeast, in vivo)
 > 10 h (E. coli, in vivo)
BEF-F 2038.2 30 h (mammalian reticulocytes, in vitro) 31 − 1 4.37 − 0.484 133.97-Unstable
 > 20 h (yeast, in vivo)
 > 10 h (E. coli, in vivo)
BEF-G 2399.7 1.9 h (mammalian reticulocytes, in vitro) 43 1.25 7.97 0.087 35.10-Stable
 > 20 h (yeast, in vivo)
 > 10 h (E.coli, in vivo)
BEF-H 2843.1 7.2 h (mammalian reticulocytes, in vitro) 33 1 9.41 0.213 34.19-Stable
 > 20 h (yeast, in vivo)
 > 10 h (E.coli, in vivo)
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studies and our study emphasize on the potential ability of 
prediction tools on B cell epitope-based vaccine candidates 
for K. pneumoniae.
If an epitopic peptide is going to be used as vaccine can-
didate, it would be essential to elucidate their structures and 
physicochemical properties. Therefore, in the present study, 
the physicochemical and structural properties of final four 
epitopes were investigated. These investigations include 
molecular weight, half-life, instability index, net charge, 
hydrophobicity, GRAVY, pI and 3D structure that all of 
them are valuable and increases the accuracy and precision 
of the epitope design (Adhikari et al. 2018). Isoelectric point 
(pI) is an important factor to select a good epitope (Cam-
pos-Pinto et al. 2019). The peptides at their own isoelectric 
point carries no net electrical charge, their immunogenicity 
is reduced because antibodies and other specific immune 
receptors such as B cell receptor prefer charged and polar 
antigen residues (Wang et al. 2018). The pH of the blood and 
the body tissues is neutral (pH 7.2–7.6), therefore, it is better 
that pI of the epitopes not be close to the pH of the blood and 
body tissues. In this study, pI of all epitopes, except BEF-G, 
is far from the physiological pH of the body.
GRAVY indicates the rate of hydrophilicity or hydro-
phobicity of a protein. Peptides with positive GRAVY are 
more hydrophobic while peptides with a negative GRAVY 
value are more hydrophilic and tend to be more water solu-
ble (Kyte and Doolittle 1982; Adhikari et al. 2018). All of 
our final epitopes were in the suitable range in this regard. 
Increasing the hydrophobic ratio in the non-polar face of 
the peptides to increase the symmetry in hydrophobic and 
hydrophilic faces, can enhanced their toxicity and hemolytic 
activity (Boland and Separovic 2006; Madanchi et al. 2019). 
Helical wheel projection showed that in all epitopes, the 
hydrophilic face became more discontinuous by polar resi-
dues, so the symmetry in hydrophobic and hydrophilic faces 
was not seen in our epitopes. Therefore, this arrangement 
reduces the possibility of cytotoxicity and hemolytic activ-
ity of these peptides to humans. This finding confirms the 
results of toxicity prediction done by ToxinPred server and 
showed that our final four epitopic peptides are non toxic.
Altogether, here we found four B cell epitopes (each for 
one Fim antigen) that are immunogen, antigenic, not similar 
to human peptides, not allergen and not toxic. They have also 
suitable physiochemical properties required for vaccine can-
didates, although their actual efficacy should be investigated 
using in vitro and in vivo testing.
It should be noted that numerous challenges can be read-
ily predictable in developing K. pneumoniae vaccines, but 
not considered in our study. The first one is the developed 
Fig. 3  The helical wheel projection of the final epitopes. The helical 
wheel projection of BEF-A (a), BEF-F (b), BEF-G (c) and BEF-H 
(d) are shown. In all epitopes, polar and non-polar amino acids are 
distributed irregularly and disrupting the uniformity of hydrophobic 
and hydrophilic faces. The amino acid residues are shown by standard 
single letters
Fig. 4  Structure prediction. 3D structure of epitopes was predicted by 
PEP-Fold3 server. The 3D structure of BEF-A, BEF-F, BEF-G, and 
BEF-H are shown in parts A, B, C, and D, respectively
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vaccines against K. pneumoniae should not have cross-reac-
tivity with the normal flora of intestine where this bacterium 
colonizes (Ahmad et al. 2012). The second, patients vulner-
able to K. pneumoniae are often elderly and suffer multiple 
comorbidities. Consequently, immune responses of these 
populations to vaccine may be poor and not induce protec-
tive immunity (Weinberger et al. 2008).
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